Home

JAISIM SHAH

CIK 1242133 · See Remarks · last filed 2024-12-18

JAISIM SHAH is a corporate insider who has filed 29 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing shows the insider bought $13.8K of SCLXW on Dec 18, 2024. Across all open-market trades the lifetime net is −$670.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $53.2K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$53.2K

Companies

3

Total Filings

29

Lifetime Open-Market Net

-$670.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SCLXW See Remarks 295,215 $0.18 $53.2K $197.2K 8 2024-12-18
Sorrento Therapeutics, Inc. (SRNE) Delisted Director 178,075 $0.00 $89 $399.7K 16 2021-08-30
PDL BIOPHARMA, INC. (PDLI) Delisted SVP, Mktg & Bus. Affairs 15,812 — — -$1.27M 5 2008-04-30

Recent Filings

29 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-12-18 SCLXW Buy (P) +30,000 $13.8K EDGAR
2024-10-29 SCLXW Buy (P) +32,000 $31.7K EDGAR
2024-10-17 SCLXW Buy (P) +30,000 $29.8K EDGAR
2024-06-20 SCLXW Exer (M) +14,000 $24.2K EDGAR
2024-06-14 SCLXW Exer (M) +33,333 $47.0K EDGAR
2024-05-17 SCLXW Buy (P) +140,000 $121.9K EDGAR
2023-10-05 SCLXW Grant (A) — $0 EDGAR
2023-01-17 SCLXW Grant (A) — $0 EDGAR
2021-08-30 Sorrento Therapeutics, Inc. (SRNE) Delisted Grant (A) — $0 EDGAR
2020-06-15 Sorrento Therapeutics, Inc. (SRNE) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 29
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.